Journals / Jinekoloji Obstetrik Pediatri ve Pediatrik Cerrahi Dergisi / 2011 / Cilt: 3 - Sayı: 2

Evaluation of Pediatric Migraine Patients

Çocukluk Migren Hastalarının Değerlendirilmesi

Pages
74–78
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Flunarizine is one of the appropriate preventive agents for migraine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the clinical features of pediatric patients diagnosed with migraine.
📊
Key Findings & Data:Methods: Patients followed with the diagnosis of migraine at child neurology outpatient clinic of Istanbul Faculty of Medicine between January 2008 and December 2009 were evaluated.
💡
Conclusion & Impact:Flunarizine is one of the appropriate preventive agents for migraine.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the clinical features of pediatric patients diagnosed with migraine. Methods: Patients followed with the diagnosis of migraine at child neurology outpatient clinic of Istanbul Faculty of Medicine between January 2008 and December 2009 were evaluated. Retrospective study design was used. International Headache Society 2004 diagnostic criteria were used for the diagnosis of migraine. Results: 55 boys and 53 girls were included into study. Mean age of boys was 10.3±2.5 years, while girls was 10±2.8 years. Headache frequency was everyday in 9 patients, 2-6 times/week in 40 patients, 1 times /week in 27 patients, 1-3 times/month in 32 patients. Family history was remarkable in 38.9 % of patients. Stress was the trigger for headache in 35 patients, noise in 14, intense light in 11, fatigue in 10, hunger in 3 and crowdedness in 3 patients. Headache was bilateral in 91.7 % of patients and unilateral in 8.3 %. Physical activity aggravates headache in 32 % of patients and headache accompanied with nausea and vomiting in 60.2 % patients, headache accompanied with phonophobiaphotophobia in 76 % of patients. After ruling out other causes of headache, analgesic drugs were used by 63 patients, while 45 of patients were evaluated for preventive therapy. Flunarizine was chosen as a preventive agent in 36 patients and 29/36 reported alleviation in pain intensity and frequency. Conclusion: Migraine in children is often bilateral and has a shorter duration. When headache is accompanied with nausea,vomiting and phonophobia-photophobia, migraine must be considered in diagnosis. Flunarizine is one of the appropriate preventive agents for migraine.

Özet

Amaç: Migren tanısı almış çocuk hastaların klinik özelliklerini ortaya koymak. Yöntemler: Çalışmaya İstanbul Üniversitesi İstanbul Tıp Fakültesi Çocuk Nörolojisi Bilim Dalı Polikliniği'nden Ocak 2008 ile Aralık 2009 tarihleri arasında migren tanısı konularak izlenen hastalar alındı. Hasta bilgilerine dosyaların retrospektif olarak incelenmesiyle ulaşıldı. Migren tanısı için Uluslararası Başağrısı Topluluğunun 2004 tanı kriterlerinden yararlanıldı. Bulgular: Çalışmaya 55'i erkek, 53'ü kız toplam 108 hasta alındı. Erkek hastaların yaş ortalaması 10.3± 2,5 yıl, kızların ise 10±2,8 yıldı. Baş ağrısı sıklığı 9 hastada her gün, 40 hastada haftada 2-6 kez, 27 hastada haftada 1 kez, 32 hastada ayda 1-3 kez olarak bildirildi. Hastaların % 38.9'unun ailesinde migren öyküsü vardı. Baş ağrısını tetikleyen faktörler 35 hastada stres, 14'ünde gürültü, 11'inde yoğun ışık, 10'unda yorgunluk, 3'ünde açlık ve 3 hastada kalabalık ortam olarak saptandı. Baş ağrısı % 91.7 hastada çift taraflıyken % 8.3 hastada tek taraflıydı. Baş ağrısı sırasında fiziksel aktivitenin % 32 hastada ağrıyı arttırdığı, % 60.2 hastada ağrıya bulantı-kusmanın eşlik ettiği, % 76 hastada ağrıya fonofobi-fotofobinin eşlik ettiği saptandı. Ağrı etiyolojisine yönelik yapılan tetkikler ile diğer nedenler dışlandıktan sonra aralıklı analjezik uygulanması 63 hastada tercih edilirken, 45 hastaya koruyucu tedavi başlanmıştı. Koruyucu tedavi olarak 36 hastada flunarizin tercih edilmişti ve 29/36 hastada ağrı şiddetinde ve sıklığında azalma olduğu bildirilmişti. Sonuç: Çocuklarda migren tipi baş ağrısının erişkinlerin aksine çoğunlukla çift taraflı oluşu, ağrının daha kısa sürmesi tanısal değerlendirmede dikkate alınmalıdır. Baş ağrısına eşlik eden bulantı-kusma ve fonofobi-fotofobi migren tipi baş ağrısını düşündürtmelidir. Çocukluk çağı migreninde koruyucu tedavi seçeneklerinden birisi de flunarizindir.

🔖

Cite This Article

SÜTÇÜ, M., ABALI, S., AYDINLI, N., BOZKURT, B., TATLI, B., EKİCİ, B. (2022). Evaluation of Pediatric Migraine Patients. Jinekoloji Obstetrik Pediatri ve Pediatrik Cerrahi Dergisi, Cilt: 3 - Sayı: 2, 74–78. https://ajindex.com/articles/558572

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Bugdayci R, Ozge A, Sasmaz T, et al. Prevalence and factors affecting headache in Turkish schoolchildren. Pediatr Int 2005;47:316-322
  2. Carlsson J. Prevalence of headache in schoolchildren: relation to family and school factors. Acta Paediatr 1996;85:692-696
  3. Ozge A, Termine C, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl Ç. Overview of diagnosis and management of paediatric headache Part I: diagnosis. J Headache Pain 2011;12:13-23
  4. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia 2004;24:1-160
  5. Karli N, Akgoz S, Zarifoglu M, Akis N, Erer S. Clinical characteristics of tension-type headache and migraine in adolescents: a student-based study. Headache 2006;46:399-412
  6. Akyol A, Kiylioglu N, Aydin I, et al. Epidemiology and clinical characteristics of migraine among school children in the Menderes region. Cephalalgia 2007;27:781-787
  7. Laurell K, Larsson B, Mattsson P, Eeg-Olofsson O. A 3-year follow-up of headache diagnoses and symptoms in Swedish schoolchildren. Cephalalgia 2006;26:809-815
  8. Hershey AD, Winner P, Kabbouche MA, et al. Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache 2005;45:1288- 1297
  9. Aydin M, Kabakus N, Bozdag S, Ertugrul S. Profile of children with migraine. Indian J Pediatr 2010;77:1247-1251
  10. Lewis KS. Pediatric headache. Semin Pediatr Neurol 2010;17:224-229
  11. Bruijn J, Duivenvoorden H, Passchier J, et al. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebocontrolled, randomised, double-blind, cross-over trial. Cephalalgia 2010;30:1426-1434
  12. Bidabadi E, Mashouf M. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Pediatr Drugs 2010;12:269-275
  13. Pandina GJ, Ness S, Polverejan E, et al. Cognitive effects of topiramate in migraine patients aged 12 through 17 years. Pediatr Neurol 2010;42:187-195.